237 related articles for article (PubMed ID: 21718297)
1. Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes.
Nalos L; Varkevisser R; Jonsson MK; Houtman MJ; Beekman JD; van der Nagel R; Thomsen MB; Duker G; Sartipy P; de Boer TP; Peschar M; Rook MB; van Veen TA; van der Heyden MA; Vos MA
Br J Pharmacol; 2012 Jan; 165(2):467-78. PubMed ID: 21718297
[TBL] [Abstract][Full Text] [Related]
2. No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.
Thomsen MB; Beekman JD; Attevelt NJ; Takahara A; Sugiyama A; Chiba K; Vos MA
Br J Pharmacol; 2006 Dec; 149(8):1039-48. PubMed ID: 17088870
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
[TBL] [Abstract][Full Text] [Related]
4. Selective late sodium current inhibitor GS-458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia.
Bossu A; Houtman MJC; Meijborg VMF; Varkevisser R; Beekman HDM; Dunnink A; de Bakker JMT; Mollova N; Rajamani S; Belardinelli L; van der Heyden MAG; Vos MA
Br J Pharmacol; 2018 Jun; 175(12):2470-2482. PubMed ID: 29582428
[TBL] [Abstract][Full Text] [Related]
5. Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog.
Dunnink A; van Opstal JM; Oosterhoff P; Winckels SK; Beekman JD; van der Nagel R; Cora Verduyn S; Vos MA
Europace; 2012 Mar; 14(3):431-6. PubMed ID: 21946817
[TBL] [Abstract][Full Text] [Related]
6. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
Jacobson I; Carlsson L; Duker G
J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
[TBL] [Abstract][Full Text] [Related]
7. Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.
Antoons G; Oros A; Beekman JD; Engelen MA; Houtman MJ; Belardinelli L; Stengl M; Vos MA
J Am Coll Cardiol; 2010 Feb; 55(8):801-9. PubMed ID: 20170820
[TBL] [Abstract][Full Text] [Related]
8. LUF7244, an allosteric modulator/activator of K
Qile M; Beekman HDM; Sprenkeler DJ; Houtman MJC; van Ham WB; Stary-Weinzinger A; Beyl S; Hering S; van den Berg DJ; de Lange ECM; Heitman LH; IJzerman AP; Vos MA; van der Heyden MAG
Br J Pharmacol; 2019 Oct; 176(19):3871-3885. PubMed ID: 31339551
[TBL] [Abstract][Full Text] [Related]
9. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.
Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D
Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351
[TBL] [Abstract][Full Text] [Related]
10. AV-block and conduction slowing prevail over TdP arrhythmias in the methoxamine-sensitized pro-arrhythmic rabbit model.
Varkevisser R; Vos MA; Beekman JD; Tieland RG; Van Der Heyden MA
J Cardiovasc Electrophysiol; 2015 Jan; 26(1):82-9. PubMed ID: 25154623
[TBL] [Abstract][Full Text] [Related]
11. Calcium antagonist property of CPU228, a dofetilide derivative, contributes to its low incidence of torsades de pointes in rabbits.
Huang ZJ; Dai DZ; Li N; Na T; Ji M; Dai Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):310-7. PubMed ID: 17324143
[TBL] [Abstract][Full Text] [Related]
12. Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model.
Varkevisser R; van der Heyden MA; Tieland RG; Beekman JD; Vos MA
Eur J Pharmacol; 2013 Nov; 720(1-3):49-54. PubMed ID: 24211677
[TBL] [Abstract][Full Text] [Related]
13. Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current.
Yang T; Chun YW; Stroud DM; Mosley JD; Knollmann BC; Hong C; Roden DM
Circulation; 2014 Jul; 130(3):224-34. PubMed ID: 24895457
[TBL] [Abstract][Full Text] [Related]
14. The electromechanical window is no better than QT prolongation to assess risk of Torsade de Pointes in the complete atrioventricular block model in dogs.
Stams TR; Bourgonje VJ; Beekman HD; Schoenmakers M; van der Nagel R; Oosterhoff P; van Opstal JM; Vos MA
Br J Pharmacol; 2014 Feb; 171(3):714-22. PubMed ID: 24490860
[TBL] [Abstract][Full Text] [Related]
15. Robust anti-arrhythmic efficacy of verapamil and flunarizine against dofetilide-induced TdP arrhythmias is based upon a shared and a different mode of action.
Oros A; Houtman MJ; Neco P; Gomez AM; Rajamani S; Oosterhoff P; Attevelt NJ; Beekman JD; van der Heyden MA; Ver Donck L; Belardinelli L; Richard S; Antoons G; Vos MA;
Br J Pharmacol; 2010 Sep; 161(1):162-75. PubMed ID: 20718748
[TBL] [Abstract][Full Text] [Related]
16. Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts.
Farkas AS; Acsai K; Tóth A; Dézsi L; Orosz S; Forster T; Csanády M; Papp JG; Varró A; Farkas A
Eur J Pharmacol; 2006 May; 537(1-3):118-25. PubMed ID: 16618484
[TBL] [Abstract][Full Text] [Related]
17. An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.
Dhein S; Perlitz F; Mohr FW
Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):631-44. PubMed ID: 18648775
[TBL] [Abstract][Full Text] [Related]
18. Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liability.
Vos MA
Br J Pharmacol; 2008 Aug; 154(7):1523-7. PubMed ID: 18604235
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
[TBL] [Abstract][Full Text] [Related]
20. Istaroxime, a positive inotropic agent devoid of proarrhythmic properties in sensitive chronic atrioventricular block dogs.
Bossu A; Kostense A; Beekman HDM; Houtman MJC; van der Heyden MAG; Vos MA
Pharmacol Res; 2018 Jul; 133():132-140. PubMed ID: 29753687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
